Scott F. Sneddon
Chief Executive Officer at Sharp Edge Labs, Inc.
Profile
Scott F.
Sneddon is currently the President, Chief Executive & Scientific Officer at Sharp Edge Labs, Inc. He previously worked as a Senior Director at Genzyme Corp.
and as a Research Scientist & Group Leader at Pfizer Inc. Dr. Sneddon holds a doctorate degree from Carnegie Mellon University and a graduate degree from The Trustees of Columbia University in The City of New York.
Scott F. Sneddon active positions
| Companies | Position | Start |
|---|---|---|
Sharp Edge Labs, Inc.
 Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Chief Executive Officer | - |
Former positions of Scott F. Sneddon
| Companies | Position | End |
|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Director/Board Member | - |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Scott F. Sneddon
| Carnegie Mellon University | Doctorate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sharp Edge Labs, Inc.
Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Commercial Services |
- Stock Market
- Insiders
- Scott F. Sneddon
